Roughly 80% of the key active pharmaceutical ingredients (APIs) in drugs sold in the European Union are imported. The vast majority are made in factories in India and China, which are not inspected by EU inspectors. Unlike the US Food and Drug Administration (FDA), European health authorities do not have a foreign inspection service.
Article / Feb 25, 2008
Chemistry & Industry, 25 February 2008